Evidence map›Paper›PMID 31013775›Full record

ArticleInternational journal of molecular sciences2019

Bumetanide-Derived Aquaporin 1 Inhibitors, AqB013 and AqB050 Inhibit Tube Formation of Endothelial Cells through Induction of Apoptosis and Impaired Migration In Vitro.

Yoko Tomita, Helen M Palethorpe, Eric Smith, Maryam Nakhjavani, Amanda R Townsend, Timothy J Price, Andrea J Yool, Jennifer E Hardingham

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Water channel protein AQP1 in cytoplasm is a critical factor in breast cancer local invasion.Journal of experimental & clinical cancer research : CR · 2023
    Article
  5. Aquaporin-mediated dysregulation of cell migration in disease states.Cellular and molecular life sciences : CMLS · 2023
    Review
  6. Methods for studying mammalian aquaporin biology.Biology methods & protocols · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Anti-Angiogenic Properties of Ginsenoside Rg3.Molecules (Basel, Switzerland) · 2020
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yoko TomitaSolid Tumour Group, Basil Hetzel Institute, Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. yoko.tomita@sa.gov.au.
Helen M PalethorpeSolid Tumour Group, Basil Hetzel Institute, Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. helen.palethorpe@adelaide.edu.au.ORCID 0000-0003-3803-5113
Eric SmithSolid Tumour Group, Basil Hetzel Institute, Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. eric.smith@adelaide.edu.au.ORCID 0000-0003-2958-3492
Maryam NakhjavaniSolid Tumour Group, Basil Hetzel Institute, Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. maryam.nakhjavani@adelaide.edu.au.ORCID 0000-0002-5357-7167
Amanda R TownsendSolid Tumour Group, Basil Hetzel Institute, Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. amanda.townsend@sa.gov.au.
Timothy J PriceSolid Tumour Group, Basil Hetzel Institute, Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. timothy.price@sa.gov.au.
Andrea J YoolAdelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia. andrea.yool@adelaide.edu.au.ORCID 0000-0003-1283-585X
Jennifer E HardinghamSolid Tumour Group, Basil Hetzel Institute, Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. jenny.hardingham@sa.gov.au.ORCID 0000-0001-8277-1199
Basil Hetzel Institute · AUThe University of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AqB013 and AqB050 compounds inhibit aquaporin 1 (AQP1), a dual water and ion channel implicated in tumour angiogenesis. We tested AqB013 and AqB050 either as monotherapy or in combination on tube formation of murine endothelial cells (2H-11 and 3B-11) and human umbilical vascular endothelial cells (HUVECs). The mechanism underlying their anti-tubulogenic effect was explored by examining cell viability, induction of apoptosis and migration using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2

Indexed as

ApoptosisAquaporin 1BumetanideCell MovementCell SurvivalEndothelial CellsHumansNeovascularization, PhysiologicAquaporin 1BumetanideangiogenesisapoptosisAqB013AqB050aquaporin 1 (AQP1)endothelial cellsmigration

Identifiers

PMID31013775
PMCPMC6515555
OpenAlexW2939020961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.